{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T02:20:11Z","timestamp":1794277211454,"version":"4.9.0"},"reference-count":75,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.jinf.2018.02.012","type":"journal-article","created":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T20:41:32Z","timestamp":1525207292000},"page":"550-562","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":63,"title":["The burden of Invasive Aspergillosis in patients with haematological malignancy: A meta-analysis and systematic review"],"prefix":"10.1016","volume":"76","author":[{"given":"R.J.","family":"van de Peppel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.G.","family":"Visser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.M.","family":"Dekkers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.G.J.","family":"de Boer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.jinf.2018.02.012_bib0001","first-page":"1068","article-title":"The epidemiology of fungal infections in patients with hematologic malignancies: the SEIFEM-2004 study","volume":"91","author":"Pagano","year":"2006","journal-title":"Haematologica"},{"issue":"3","key":"10.1016\/j.jinf.2018.02.012_bib0002","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1086\/318483","article-title":"Aspergillosis case-fatality rate: systematic review of the literature","volume":"32","author":"Lin","year":"2001","journal-title":"Clin Infect Dis"},{"issue":"11","key":"10.1016\/j.jinf.2018.02.012_bib0003","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1086\/517849","article-title":"Invasive aspergillosis in patients with acute leukemia: update on morbidity and mortality\u2013SEIFEM-C report","volume":"44","author":"Pagano","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.jinf.2018.02.012_bib0004","doi-asserted-by":"crossref","first-page":"ofw268","DOI":"10.1093\/ofid\/ofw268","article-title":"Trends in hospitalizations related to invasive aspergillosis and mucormycosis in the United States, 2000\u20132013","volume":"4","author":"Vallabhaneni","year":"2017","journal-title":"Open Forum Infect Dis"},{"issue":"3","key":"10.1016\/j.jinf.2018.02.012_bib0005","doi-asserted-by":"crossref","first-page":"335","DOI":"10.2217\/fmb.11.4","article-title":"Azole resistance in Aspergillus fumigatus: a new challenge in the management of invasive aspergillosis?","volume":"6","author":"Snelders","year":"2011","journal-title":"Futur. Microbiol"},{"issue":"11","key":"10.1016\/j.jinf.2018.02.012_bib0006","doi-asserted-by":"crossref","first-page":"e219","DOI":"10.1371\/journal.pmed.0050219","article-title":"Emergence of azole resistance in Aspergillus fumigatus and spread of a single resistance mechanism","volume":"5","author":"Snelders","year":"2008","journal-title":"PLoS Med"},{"issue":"5","key":"10.1016\/j.jinf.2018.02.012_bib0007","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1093\/jac\/dku566","article-title":"Emergence of azole-resistant invasive aspergillosis in HSCT recipients in Germany","volume":"70","author":"Steinmann","year":"2015","journal-title":"J Antimicrob Chemother"},{"issue":"12","key":"10.1016\/j.jinf.2018.02.012_bib0008","doi-asserted-by":"crossref","first-page":"e383","DOI":"10.1016\/S1473-3099(17)30316-X","article-title":"The global problem of antifungal resistance: prevalence, mechanisms, and management","volume":"17","author":"Perlin","year":"2017","journal-title":"Lancet Infect Dis"},{"issue":"12","key":"10.1016\/j.jinf.2018.02.012_bib0009","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1086\/588660","volume":"46","author":"De Pauw","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.jinf.2018.02.012_bib0010","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1093\/cid\/ciu911","volume":"60","author":"Herbrecht","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.jinf.2018.02.012_bib0011","doi-asserted-by":"crossref","first-page":"538","DOI":"10.3109\/13693786.2011.630040","article-title":"Impact of the revised (2008) EORTC\/MSG definitions for invasive fungal disease on the rates of diagnosis of invasive aspergillosis","volume":"50","author":"Tsitsikas","year":"2012","journal-title":"Med Mycol"},{"key":"10.1016\/j.jinf.2018.02.012_bib0012","doi-asserted-by":"crossref","unstructured":"Dragonetti G, Criscuolo M, Fianchi L, Pagano L. Invasive aspergillosis in acute myeloid leukemia: are we making progress in reducing mortality? Med Mycol. 2017;55(1):82\u20136.","DOI":"10.1093\/mmy\/myw114"},{"issue":"8","key":"10.1016\/j.jinf.2018.02.012_bib0013","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1086\/651263","article-title":"Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001\u20132006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database","volume":"50","author":"Kontoyiannis","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.jinf.2018.02.012_bib0014","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/ciw326","article-title":"Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the Infectious Diseases Society of America","volume":"63","author":"Patterson","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.jinf.2018.02.012_bib0015","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/bmt.2010.175","article-title":"European guidelines for antifungal management in leukemia and hematopoietic stem cell transplant recipients: summary of the ECIL 3\u20132009 update","volume":"46","author":"Maertens","year":"2011","journal-title":"Bone Marrow Transplant"},{"issue":"7","key":"10.1016\/j.jinf.2018.02.012_bib0016","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med"},{"key":"10.1016\/j.jinf.2018.02.012_bib0017","unstructured":"Wells GA, Shea B, O'Connell D, Peterson J, Welch V, Losos M, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses, 2018. Available from:\u00a0http:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp."},{"issue":"1","key":"10.1016\/j.jinf.2018.02.012_bib0018","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/2049-3258-72-39","article-title":"Metaprop: a Stata command to perform meta-analysis of binomial data","volume":"72","author":"Nyaga","year":"2014","journal-title":"Arch Public Health"},{"issue":"6","key":"10.1016\/j.jinf.2018.02.012_bib0019","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.bbmt.2014.03.004","article-title":"Incidence and outcome of invasive fungal diseases after allogeneic stem cell transplantation: a prospective study of the gruppo italiano trapianto midollo osseo (GITMO)","volume":"20","author":"Girmenia","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jinf.2018.02.012_bib0020","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciu673","article-title":"Serum galactomannan-based early detection of invasive aspergillosis in hematology patients receiving effective anti-mold prophylaxis","author":"Duarte","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.jinf.2018.02.012_bib0021","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1128\/AAC.01525-13","article-title":"Incidence density of invasive fungal infections during primary antifungal prophylaxis in newly diagnosed acute myeloid leukemia patients in a tertiary cancer center, 2009\u20132011","volume":"58","author":"Gomes","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"issue":"11","key":"10.1016\/j.jinf.2018.02.012_bib0022","doi-asserted-by":"crossref","first-page":"O952","DOI":"10.1111\/1469-0691.12688","article-title":"Breakthrough invasive fungal disease in patients receiving posaconazole primary prophylaxis: a 4-year study","volume":"20","author":"Lerolle","year":"2014","journal-title":"Clin Microbiol Infect"},{"issue":"7","key":"10.1016\/j.jinf.2018.02.012_bib0023","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1093\/jac\/dkq121","article-title":"Clinical effectiveness of posaconazole prophylaxis in patients with acute myelogenous leukaemia (AML): a 6 year experience of the Cologne AML cohort","volume":"65","author":"Vehreschild","year":"2010","journal-title":"J Antimicrob Chemother"},{"issue":"Suppl. 1","key":"10.1016\/j.jinf.2018.02.012_bib0024","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1439-0507.2010.01979.x","article-title":"Posaconazole prophylaxis in patients with acute myelogenous leukaemia \u2013 results from an observational study","volume":"54","author":"Egerer","year":"2011","journal-title":"Mycoses"},{"issue":"2","key":"10.1016\/j.jinf.2018.02.012_bib0025","doi-asserted-by":"crossref","first-page":"E86","DOI":"10.9778\/cmajo.20130062","article-title":"Incidence of invasive aspergillosis following remission-induction chemotherapy for acute leukemia: a retrospective cohort study in a single Canadian tertiary care centre","volume":"2","author":"Barkati","year":"2014","journal-title":"CMAJ Open"},{"issue":"6","key":"10.1016\/j.jinf.2018.02.012_bib0026","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1007\/s10096-011-1397-5","article-title":"Invasive aspergillosis: an important risk factor on the short- and long-term survival of acute myeloid leukemia (AML) patients","volume":"31","author":"Michallet","year":"2012","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"8","key":"10.1016\/j.jinf.2018.02.012_bib0027","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1111\/1469-0691.12002","article-title":"Invasive fungal diseases in haematopoietic cell transplant recipients and in patients with acute myeloid leukaemia or myelodysplasia in Brazil","volume":"19","author":"Nucci","year":"2013","journal-title":"Clin Microbiol Infect"},{"issue":"2","key":"10.1016\/j.jinf.2018.02.012_bib0028","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/ejh.12565","article-title":"Decreased invasive fungal disease but no impact on overall survival by posaconazole compared to fluconazole prophylaxis: a retrospective cohort study in patients receiving induction therapy for acute myeloid leukaemia\/myelodysplastic syndromes","volume":"96","author":"Dahlen","year":"2016","journal-title":"Eur J Haematol"},{"issue":"7","key":"10.1016\/j.jinf.2018.02.012_bib0029","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1093\/mmy\/myu036","article-title":"Relapsed and secondary disease drive the risk profile for invasive aspergillosis prior to stem cell transplantation in patients with acute myeloid leukemia or myelodysplastic syndrome","volume":"52","author":"van de Peppel","year":"2014","journal-title":"Med Mycol"},{"issue":"4","key":"10.1016\/j.jinf.2018.02.012_bib0030","doi-asserted-by":"crossref","first-page":"560","DOI":"10.3324\/haematol.2011.053058","article-title":"Posaconazole prophylaxis during front-line chemotherapy of acute myeloid leukemia: a single-center, real-life experience","volume":"97","author":"Girmenia","year":"2012","journal-title":"Haematologica"},{"issue":"1","key":"10.1016\/j.jinf.2018.02.012_bib0031","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/bmt.2010.76","article-title":"Addition of aerosolized deoxycholate amphotericin B to systemic prophylaxis to prevent airways invasive fungal infections in allogeneic hematopoietic SCT: a single-center retrospective study","volume":"46","author":"Morello","year":"2011","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"10.1016\/j.jinf.2018.02.012_bib0032","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1399-3062.2011.00661.x","article-title":"Low incidence of invasive aspergillosis in allogeneic stem cell transplant recipients receiving amphotericin B inhalation prophylaxis","volume":"14","author":"Nihtinen","year":"2012","journal-title":"Transpl Infect Dis"},{"issue":"5","key":"10.1016\/j.jinf.2018.02.012_bib0033","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1111\/tid.12115","article-title":"Increased susceptibility for aspergillosis and post-transplant immune deficiency in patients with gene variants of TLR4 after stem cell transplantation","volume":"15","author":"Koldehoff","year":"2013","journal-title":"Transpl Infect Dis"},{"issue":"4","key":"10.1016\/j.jinf.2018.02.012_bib0034","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1002\/jmv.23735","article-title":"An investigation on the relationship between the occurrence of CMV DNAemia and the development of invasive aspergillosis in the allogeneic stem cell transplantation setting","volume":"86","author":"Gimenez","year":"2014","journal-title":"J Med Virol"},{"issue":"24","key":"10.1016\/j.jinf.2018.02.012_bib0035","doi-asserted-by":"crossref","first-page":"5111","DOI":"10.1182\/blood-2010-02-268151","article-title":"Randomized, double-blind trial of fluconazole versus voriconazole for prevention of invasive fungal infection after allogeneic hematopoietic cell transplantation","volume":"116","author":"Wingard","year":"2010","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.jinf.2018.02.012_bib0036","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1093\/cid\/ciu673","article-title":"Serum galactomannan-based early detection of invasive aspergillosis in hematology patients receiving effective antimold prophylaxis","volume":"59","author":"Duarte","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"11","key":"10.1016\/j.jinf.2018.02.012_bib0037","doi-asserted-by":"crossref","first-page":"e27962","DOI":"10.1371\/journal.pone.0027962","article-title":"Genetically-determined hyperfunction of the S100B\/RAGE axis is a risk factor for aspergillosis in stem cell transplant recipients","volume":"6","author":"Cunha","year":"2011","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.jinf.2018.02.012_bib0038","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.leukres.2014.01.007","article-title":"Invasive fungal diseases during first induction chemotherapy affect complete remission achievement and long-term survival of patients with acute myeloid leukemia","volume":"38","author":"Girmenia","year":"2014","journal-title":"Leuk Res"},{"issue":"8","key":"10.1016\/j.jinf.2018.02.012_bib0039","doi-asserted-by":"crossref","first-page":"818","DOI":"10.3109\/13693786.2013.809630","article-title":"TLR5 stop codon polymorphism is associated with invasive aspergillosis after allogeneic stem cell transplantation","volume":"51","author":"Grube","year":"2013","journal-title":"Med Mycol"},{"issue":"3","key":"10.1016\/j.jinf.2018.02.012_bib0040","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/tid.12060","article-title":"Epidemiology, outcomes, and mortality predictors of invasive mold infections among transplant recipients: a 10-year, single-center experience","volume":"15","author":"Neofytos","year":"2013","journal-title":"Transpl Infect Dis"},{"issue":"2","key":"10.1016\/j.jinf.2018.02.012_bib0041","doi-asserted-by":"crossref","first-page":"100","DOI":"10.3109\/00365548.2011.623311","article-title":"Risk factors for invasive mold infections following allogeneic hematopoietic stem cell transplantation: a single center study of 190 recipients","volume":"44","author":"Li","year":"2012","journal-title":"Scand J Infect Dis"},{"issue":"4","key":"10.1016\/j.jinf.2018.02.012_bib0042","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1111\/j.1399-3062.2010.00497.x","article-title":"Risk factors and prognosis of invasive fungal infections in allogeneic stem cell transplantation recipients: a single-institution experience","volume":"12","author":"Zhang","year":"2010","journal-title":"Transpl Infect Dis"},{"issue":"6","key":"10.1016\/j.jinf.2018.02.012_bib0043","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1093\/infdis\/jiv143","article-title":"Immune reconstitution after allogeneic hematopoietic stem cell transplantation and association with occurrence and outcome of invasive aspergillosis","volume":"212","author":"Stuehler","year":"2015","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.jinf.2018.02.012_bib0044","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ijantimicag.2015.02.023","article-title":"Aerosolised liposomal amphotericin B to prevent aspergillosis in acute myeloid leukaemia: efficacy and cost effectiveness in real-life","volume":"46","author":"Chong","year":"2015","journal-title":"Int J Antimicrob Agents"},{"issue":"6","key":"10.1016\/j.jinf.2018.02.012_bib0045","doi-asserted-by":"crossref","first-page":"996","DOI":"10.3324\/haematol.2009.012633","article-title":"Prophylaxis of invasive aspergillosis with voriconazole or caspofungin during building work in patients with acute leukemia","volume":"95","author":"Chabrol","year":"2010","journal-title":"Haematologica"},{"issue":"6","key":"10.1016\/j.jinf.2018.02.012_bib0046","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1007\/s12185-012-1210-y","article-title":"Epidemiology and treatment outcome of invasive fungal infections in patients with hematological malignancies","volume":"96","author":"Kurosawa","year":"2012","journal-title":"Int J Hematol"},{"issue":"3","key":"10.1016\/j.jinf.2018.02.012_bib0047","first-page":"237","article-title":"Breakthrough invasive fungal diseases during voriconazole treatment for aspergillosis: a 5-year retrospective cohort study","volume":"55","author":"Kim","year":"2017","journal-title":"Med Mycol"},{"issue":"6","key":"10.1016\/j.jinf.2018.02.012_bib0048","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.ijantimicag.2007.07.026","article-title":"Breakthrough invasive aspergillosis in allogeneic haematopoietic stem cell transplant recipients treated with caspofungin","volume":"30","author":"Madureira","year":"2007","journal-title":"Int J Antimicrob Agents"},{"issue":"10","key":"10.1016\/j.jinf.2018.02.012_bib0049","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.3201\/eid1710.110226","article-title":"Clinical implications of azole resistance in Aspergillus fumigatus, The Netherlands, 2007\u20132009","volume":"17","author":"van der Linden","year":"2011","journal-title":"Emerg Infect Dis"},{"issue":"3","key":"10.1016\/j.jinf.2018.02.012_bib0050","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0120370","article-title":"Causes of death in a contemporary cohort of patients with invasive aspergillosis","volume":"10","author":"Garcia-Vidal","year":"2015","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.jinf.2018.02.012_bib0051","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1038\/bmt.2017.71","article-title":"A new time-dependent approach for assessment of the impact of invasive aspergillosis shows effect on short- but not on long-term survival of patients with AML or high-risk MDS","volume":"52","author":"van de Peppel","year":"2017","journal-title":"Bone Marrow Transplant"},{"issue":"4","key":"10.1016\/j.jinf.2018.02.012_bib0052","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/s15010-016-0873-3","article-title":"Polymicrobial pulmonary infection in patients with hematological malignancies: prevalence, co-pathogens, course and outcome","volume":"44","author":"Hardak","year":"2016","journal-title":"Infection"},{"issue":"6","key":"10.1016\/j.jinf.2018.02.012_bib0053","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/bmt.2009.39","article-title":"Risk factors for invasive aspergillosis and related mortality in recipients of allogeneic SCT from alternative donors: an analysis of 306 patients","volume":"44","author":"Mikulska","year":"2009","journal-title":"Bone Marrow Transplant"},{"issue":"6","key":"10.1016\/j.jinf.2018.02.012_bib0054","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1111\/myc.12081","article-title":"Epidemiology and sites of involvement of invasive fungal infections in patients with haematological malignancies: a 20-year autopsy study","volume":"56","author":"Lewis","year":"2013","journal-title":"Mycoses"},{"issue":"5","key":"10.1016\/j.jinf.2018.02.012_bib0055","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/j.1439-0507.2012.02169.x","article-title":"Trends in the prevalence of invasive fungal infections from an analysis of annual records of autopsy cases of Toho University","volume":"55","author":"Shimodaira","year":"2012","journal-title":"Mycoses"},{"issue":"3","key":"10.1016\/j.jinf.2018.02.012_bib0056","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.jinf.2013.04.020","article-title":"Prevention and diagnosis of invasive fungal disease in high-risk patients within an integrative care pathway","volume":"67","author":"Barnes","year":"2013","journal-title":"J Infect"},{"issue":"9","key":"10.1016\/j.jinf.2018.02.012_bib0057","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1093\/jac\/dkr271","article-title":"A randomized comparison of caspofungin versus antifungal prophylaxis according to investigator policy in acute leukaemia patients undergoing induction chemotherapy (PROFIL-C study)","volume":"66","author":"Cattaneo","year":"2011","journal-title":"J Antimicrob Chemother"},{"issue":"5","key":"10.1016\/j.jinf.2018.02.012_bib0058","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1111\/ejh.12368","article-title":"Feasibility and effectiveness of posaconazole prophylaxis in combination with micafungin bridging for patients undergoing allogeneic stem cell transplantation: a 6-yr analysis from the cologne cohort for neutropenic patients","volume":"93","author":"Vehreschild","year":"2014","journal-title":"Eur J Haematol"},{"issue":"3","key":"10.1016\/j.jinf.2018.02.012_bib0059","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1111\/ejh.12426","article-title":"Primary antifungal prophylaxis with micafungin in patients with haematological malignancies: real-life data from a retrospective single-centre observational study","volume":"94","author":"Nachbaur","year":"2015","journal-title":"Eur J Haematol"},{"issue":"11","key":"10.1016\/j.jinf.2018.02.012_bib0060","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.3324\/haematol.2011.044636","article-title":"Invasive aspergillosis in patients with hematologic malignancies: incidence and description of 127 cases enrolled in a single institution prospective survey from 2004 to 2009","volume":"96","author":"Nicolle","year":"2011","journal-title":"Haematologica"},{"issue":"2","key":"10.1016\/j.jinf.2018.02.012_bib0061","doi-asserted-by":"crossref","first-page":"07","DOI":"10.1038\/bmt.2014.229","article-title":"Fungal and viral infections after allogeneic hematopoietic transplantation from unrelated donors in adults: improving outcomes over time","volume":"50","author":"Parody","year":"2015","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"10.1016\/j.jinf.2018.02.012_bib0062","doi-asserted-by":"crossref","first-page":"01","DOI":"10.1016\/j.cmi.2015.09.009","article-title":"Prospective multicentre PCR-based Aspergillus DNA screening in high-risk patients with and without primary antifungal mould prophylaxis","volume":"22","author":"Springer","year":"2016","journal-title":"Clin Microbiol Infect"},{"issue":"5","key":"10.1016\/j.jinf.2018.02.012_bib0063","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1007\/s12185-014-1529-7","article-title":"A prospective feasibility study of primary prophylaxis against invasive fungal disease with voriconazole following umbilical cord blood transplantation with fludarabine-based conditioning","volume":"99","author":"Takagi","year":"2014","journal-title":"Int J Hematol"},{"issue":"3","key":"10.1016\/j.jinf.2018.02.012_bib0064","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1093\/cid\/ciu833","article-title":"Serum galactomannan versus a combination of galactomannan and polymerase chain reaction-based Aspergillus DNA detection for early therapy of invasive aspergillosis in high-risk hematological patients: a randomized controlled trial","volume":"60","author":"Aguado","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.jinf.2018.02.012_bib0065","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/tid.12529","article-title":"Anti-Aspergillus immunoglobulin-G testing in serum of hematopoietic stem cell transplant recipients","volume":"18","author":"Erdmann","year":"2016","journal-title":"Transpl Infect Dis"},{"issue":"1","key":"10.1016\/j.jinf.2018.02.012_bib0066","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.clml.2013.09.014","article-title":"Patterns of infection in patients with myelodysplastic syndromes and acute myeloid leukemia receiving azacitidine as salvage therapy. Implications for primary antifungal prophylaxis","volume":"14","author":"Falantes","year":"2014","journal-title":"Clin Lymphoma Myeloma Leuk."},{"issue":"6","key":"10.1016\/j.jinf.2018.02.012_bib0067","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/myc.12320","article-title":"Hospital environment fungal contamination and aspergillosis risk in acute leukaemia patients in Sousse (Tunisia)","volume":"58","author":"Gheith","year":"2015","journal-title":"Mycoses"},{"issue":"8","key":"10.1016\/j.jinf.2018.02.012_bib0068","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.3109\/10428194.2012.659735","article-title":"Non-bacterial infections in Asian patients treated with alemtuzumab: a retrospective study of the Asian Lymphoma Study Group","volume":"53","author":"Kim","year":"2012","journal-title":"Leuk Lymphoma"},{"issue":"6","key":"10.1016\/j.jinf.2018.02.012_bib0069","doi-asserted-by":"crossref","first-page":"e424","DOI":"10.1016\/j.ijid.2012.01.015","article-title":"Healthcare-associated infection in hematopoietic stem cell transplantation patients: risk factors and impact on outcome","volume":"16","author":"Mendes","year":"2012","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.jinf.2018.02.012_bib0070","doi-asserted-by":"crossref","unstructured":"Pomares H, Arnan M, Sanchez-Ortega I, Sureda A, Duarte RF. Invasive fungal infections in AML\/MDS patients treated with azacitidine: a risk worth considering antifungal prophylaxis? Mycoses. 2016;59(8):516\u20139.","DOI":"10.1111\/myc.12500"},{"key":"10.1016\/j.jinf.2018.02.012_bib0071","doi-asserted-by":"crossref","DOI":"10.1111\/ina.12108","article-title":"Evaluation of invasive aspergillosis risk of immunocompromised patients alternatively hospitalized in hematology intensive care unit and at home","author":"Rocchi","year":"2014","journal-title":"Indoor Air"},{"issue":"3","key":"10.1016\/j.jinf.2018.02.012_bib0072","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1111\/tid.12527","article-title":"Diagnostic performance of 1,3-beta-D-glucan serum screening in patients receiving hematopoietic stem cell transplantation","volume":"18","author":"Reischies","year":"2016","journal-title":"Transpl Infect Dis"},{"issue":"6","key":"10.1016\/j.jinf.2018.02.012_bib0073","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S1473-3099(13)70076-8","article-title":"Galactomannan and PCR versus culture and histology for directing use of antifungal treatment for invasive aspergillosis in high-risk haematology patients: a randomised controlled trial","volume":"13","author":"Morrissey","year":"2013","journal-title":"Lancet Infect Dis"},{"issue":"5","key":"10.1016\/j.jinf.2018.02.012_bib0074","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.jinf.2015.02.012","article-title":"False-positive Aspergillus galactomannan and its kinetics in allogeneic hematopoietic stem cell transplantation","volume":"70","author":"Kimura","year":"2015","journal-title":"J Infect"},{"issue":"5-6","key":"10.1016\/j.jinf.2018.02.012_bib0075","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s11046-015-9865-6","article-title":"Invasive aspergillosis in neutropenic patients during hospital renovation: effectiveness of mechanical preventive measures in a prospective cohort of 438 patients","volume":"179","author":"Loschi","year":"2015","journal-title":"Mycopathologia"}],"container-title":["Journal of Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445318301026?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445318301026?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T21:25:25Z","timestamp":1759008325000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163445318301026"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":75,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["S0163445318301026"],"URL":"https:\/\/doi.org\/10.1016\/j.jinf.2018.02.012","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.733175739.793562610","asserted-by":"object"}]},"ISSN":["0163-4453"],"issn-type":[{"value":"0163-4453","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The burden of Invasive Aspergillosis in patients with haematological malignancy: A meta-analysis and systematic review","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jinf.2018.02.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The British Infection Association. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}